Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Baricitinib is an effective treatment for severe alopecia areata.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

A natural compound called VB-1 can help promote hair growth by boosting a specific cell signal in human skin cells.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Gefitinib can cause rare scarring hair loss.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Vitamin A helps rabbit skin cells grow and survive heat stress.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.